Boston Partners Buys 51,116 Shares of Addus HomeCare Co. (NASDAQ:ADUS)

Boston Partners raised its position in Addus HomeCare Co. (NASDAQ:ADUS - Free Report) by 41.7% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 173,697 shares of the company's stock after acquiring an additional 51,116 shares during the quarter. Boston Partners owned approximately 0.96% of Addus HomeCare worth $22,032,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently modified their holdings of the company. Quarry LP bought a new position in shares of Addus HomeCare during the 3rd quarter worth approximately $28,000. Smartleaf Asset Management LLC boosted its position in Addus HomeCare by 324.2% during the fourth quarter. Smartleaf Asset Management LLC now owns 280 shares of the company's stock worth $35,000 after purchasing an additional 214 shares during the period. Parkside Financial Bank & Trust boosted its position in Addus HomeCare by 38.6% during the fourth quarter. Parkside Financial Bank & Trust now owns 531 shares of the company's stock worth $67,000 after purchasing an additional 148 shares during the period. KBC Group NV increased its holdings in shares of Addus HomeCare by 49.1% in the fourth quarter. KBC Group NV now owns 814 shares of the company's stock valued at $102,000 after purchasing an additional 268 shares during the last quarter. Finally, GAMMA Investing LLC raised its position in shares of Addus HomeCare by 34.5% in the fourth quarter. GAMMA Investing LLC now owns 1,258 shares of the company's stock valued at $158,000 after purchasing an additional 323 shares during the period. Institutional investors own 95.35% of the company's stock.

Remove Ads

Addus HomeCare Stock Up 4.4 %

Shares of ADUS traded up $4.03 during trading hours on Tuesday, hitting $95.01. 187,256 shares of the company were exchanged, compared to its average volume of 148,824. The company has a market cap of $1.73 billion, a price-to-earnings ratio of 21.74, a P/E/G ratio of 1.41 and a beta of 0.97. The firm's fifty day moving average is $111.13 and its 200 day moving average is $121.48. Addus HomeCare Co. has a fifty-two week low of $87.88 and a fifty-two week high of $136.72.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last released its earnings results on Monday, February 24th. The company reported $1.26 EPS for the quarter, missing the consensus estimate of $1.35 by ($0.09). The firm had revenue of $297.14 million during the quarter, compared to the consensus estimate of $291.04 million. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. Analysts anticipate that Addus HomeCare Co. will post 4.59 EPS for the current year.

Insider Activity at Addus HomeCare

In other Addus HomeCare news, CEO R Dirk Allison sold 25,000 shares of the firm's stock in a transaction on Thursday, January 2nd. The stock was sold at an average price of $124.76, for a total value of $3,119,000.00. Following the sale, the chief executive officer now owns 79,397 shares of the company's stock, valued at approximately $9,905,569.72. This trade represents a 23.95 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 4.60% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

Several research analysts have weighed in on the stock. JMP Securities began coverage on shares of Addus HomeCare in a report on Monday, December 16th. They issued an "outperform" rating and a $150.00 price target on the stock. Macquarie reiterated an "outperform" rating and set a $129.00 target price on shares of Addus HomeCare in a research note on Thursday, February 27th. StockNews.com cut Addus HomeCare from a "buy" rating to a "hold" rating in a report on Wednesday, February 26th. Oppenheimer upped their price objective on Addus HomeCare from $145.00 to $150.00 and gave the company an "outperform" rating in a report on Friday, January 24th. Finally, Stephens reissued an "overweight" rating and set a $142.00 target price on shares of Addus HomeCare in a report on Wednesday, March 12th. One investment analyst has rated the stock with a sell rating, one has issued a hold rating, seven have issued a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $132.78.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.